Preprint Hypothesis Version 1 Preserved in Portico This version is not peer-reviewed

Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases

Version 1 : Received: 31 May 2020 / Approved: 31 May 2020 / Online: 31 May 2020 (20:43:13 CEST)

How to cite: Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints 2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1 Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints 2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1

Abstract

Neurodegenerative diseases of protein misfolding affect humans and animals. In humans, these diseases include Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Western Pacific amyotrophic lateral sclerosis and Parkinsonism-dementia complex (ALS/PDC). Mineral exposure may be important in the pathogenesis of protein misfolding cascades. The possible association of bentonite, montmorillonite, and mineral risk factors with Alzheimer’s disease, Parkinson’s disease, ALS, and Western Pacific ALS/PDC is analyzed and discussed.

Keywords

neurodegeneration; protein misfolding; Western Pacific; Guam; montmorillonite; bentonite; clay; mineral; ALS; Parkinson’s disease

Subject

Medicine and Pharmacology, Pathology and Pathobiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.